# To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

> **NCT00525278** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 67 (actual)

## Conditions studied

- Rhinitis
- Allergic
- Seasonal

## Interventions

- **DRUG:** Levocetirizine dihydrochloride

## Key facts

- **NCT ID:** NCT00525278
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525278, "To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00525278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*